Information från ABG Sundal Collier

Här finner du information kring börsens mindre och medelstora bolag. Avsändare är ABG Sundal Collier, innehållet är inte skapat av placera.nu:s redaktion.

« Tillbaka

Careium - Growth's comeback tour continues

10 juli 2026

<a id="bm-comp-bbbc50ea-2b16-409a-82e3-40a642beb6c1" name="bm-comp-bbbc50ea-2b16-409a-82e3-40a642beb6c1" class="BMCustomAnchor"></a><table><tr><td bm-component-id="bbbc50ea-2b16-409a-82e3-40a642beb6c1" style="vertical-align: top; width:100.000000%;"><ul><li>Q2 sales 10% above our ests. at SEK 251m, for 26% org. growth</li><li>Adj. EBIT SEK 15m vs. ABGSCe 10m</li><li>Trading at 12x-9x '26e-'27e EV/EBITA adj.</li></ul></td></tr></table><a id="bm-comp-cb213a97-709d-4609-98fe-2ab04f0b2888" name="bm-comp-cb213a97-709d-4609-98fe-2ab04f0b2888" class="BMCustomAnchor"></a><table><tr><td bm-component-id="cb213a97-709d-4609-98fe-2ab04f0b2888" style="vertical-align: top; width:100.000000%;"><h3 class="bm-h3">An exceptional growth quarter on a forgiving comp</h3><p>Q2 came in better than expected on all accounts. Careium delivered sales of SEK 251m (10% vs ABGSCe 228m), corresponding to y-o-y organic growth ex. FX of 25.6% (12.6pp vs ABGSCe 13.0%). Segment wise, service sales was SEK 179m, and product sales was SEK 72m. The gross margin decreased by 0.8pp to 42.5% (0.3pp vs ABGSCe 42.2%). Opex came in at SEK -92m (7% vs ABGSCe -86m). EBIT amounted to SEK 15m (48% vs ABGSCe 10m), for a margin of 6.0% (1.5pp vs ABGSCe 4.5%), vs. 4.9% Q2'25. The Nordics grew by 14%, and all remanding regions reported growth above 30%, which is impressive. The only sub-segment that was down was product sales in the Nordics. However, keep in mind that Q2'25 posted -12% growth, providing light comps. FCF was positive in the quarter and came in at SEK 4.7m (vs. 1m Q2'25), driven by the strong earnings but somewhat dragged down by working capital build-up. H1'26 FCF is still negative, at SEK -9m.</p><h3 class="bm-h3">Well on its way but not quite there yet</h3><p>We are encouraged by the better-than-expected earnings, and believe that Careium still has room to increase its margins going forward. While the EBIT margin improved y-o-y, earnings are still being weighed down by product development, partly driven by a lower capitalisation ratio, and growth initiatives. The gross margin was also negatively affected by an installation project of SEK 5.5m with a "limited margin", in connection with the A2D transformation in the UK. Moreover, the previously mentioned onboarding of a large contract in Norway continued to add margin pressure through upfront costs. The technical integration is described as complete, which could be read as the margin drag from onboarding starting to roll off, but management doesn't say this explicitly for guidance purposes.</p><h3 class="bm-h3">Hybrid loan settled, creating a possibility of dividends</h3><p>We also note, from <a data-bm-trackable="false" href="https://storage.mfn.se/db4c4721-6346-47c4-9b08-3bb224d8ad9a/careium-repays-hybrid-loan-to-simplify-capital-structure.pdf" target="_blank">yesterday's press release</a>, that Careium will fully settle its SEK 64m hybrid loan to its former owner Doro. It will pay SEK 35m in July '26, and the remaining SEK 29m will be written off, increasing retained earnings in Q3'26. This does not affect earnings because the hybrid loan was already accounted for as equity. Mainly funded by existing cash, but it may need to draw on its credit facility. The main positive is that Careium is now free to distribute dividends, which the hybrid loan previously did not allow. <font color="#212529">On our unrevised estimates, the share is trading at 12x-9x</font> <font color="#212529">&#8216;26e-'27e EV/EBITA adj.</font> The positive mechanical effect for consensus '26e-'28e EBIT should be within a mid-single-digit range. We hope to get more details on during the <font color="#212529">conference call at 10.30 CET</font>. Link to the webcast <a data-bm-trackable="false" href="https://www.youtube.com/live/Xzg_hG6eif4" target="_blank">here</a>.</p><table id="bm-img-f4f4a540-157d-4d08-a856-6777d73bd93b" class="bm-img-table xslt-img-empty xslt-img-include"><tr><td class="xslt-img-caption">Deviation table</td></tr><tr><td><img bm-img-encrypt="f4f4a540-157d-4d08-a856-6777d73bd93b" bm-img-original-height="730" bm-img-original-width="684" bm-img-svg="image:image_upload/97394_744bc30e-1f98-4097-86a3-a7941d51b27e.svg" bm-img-width-hint="93.95%" id="bm-id-fc566cb3-af68-419b-a616-64c7e4ed0b4e" src="https://abgsc.bluematrix.com/images/image_upload/97394_744bc30e-1f98-4097-86a3-a7941d51b27e_683.png" svg="/nas/web/clients/abgsc/images/image_upload/97394_744bc30e-1f98-4097-86a3-a7941d51b27e.svg" width="683" alt="" title="" /></td></tr><tr><td class="xslt-img-source">Source: ABG Sundal Collier, company data</td></tr></table></td></tr></table>

Senaste artiklar från alla bolag

Datum Titel Bolag Typ
2026-07-24 Cavotec - Low-margin legacy orders weigh on Q2 Cavotec Analys
2026-07-24 Cavotec - P&M order momentum sustained Cavotec Analys
2026-07-22 Inission - Strong trend to continue Inission Analys
2026-07-22 SinterCast - Q2 still tough, but we see tailwinds... SinterCast Analys
2026-07-22 Medicover - No symptoms of surprise in Q2 Medicover Analys
2026-07-22 Ework Group - Cautious optimism Ework Group Analys
2026-07-22 Donkey Republic - Helsinki deal offers further de... Donkey Repu.. Analys
2026-07-22 Medicover - In line report, reiterated targets Medicover Analys
2026-07-21 Embellence Group - Broad progress in the DTC stra... Embellence .. Analys
2026-07-21 Eltel - Earnings improve, but less than we hoped Eltel Analys
2026-07-21 CTT Systems - Getting closer to lift-off CTT Systems Analys
2026-07-21 CTT Systems - Better Q2 and OK FY'26 guidance on ... CTT Systems Analys
2026-07-21 Ework Group - Order intake turns the corner Ework Group Analys
2026-07-21 Embellence Group - Sales miss, margins resilient Embellence .. Analys
2026-07-20 Studsvik - DRPS turns, Scandpower awaits H2 Studsvik Analys
2026-07-20 Qliro - NCI miss, but TPV growth still healthy Qliro Analys
2026-07-20 Ferronordic - Positioning itself for a strong H2 Ferronordic Analys
2026-07-19 Prevas - Organic recovery delayed further Prevas Analys
2026-07-19 Ovzon - Ramping costs now for bigger wins later Ovzon Analys
2026-07-19 Alligo - Finland again ahead of plan in a solid Q2 Alligo Analys